23andMe’s Dr. Emily Drabant Conley to Speak at 2016 WAFSF

We are thrilled to have Dr. Emily Drabant Conley, Vice President of Business Development, 23andMeĀ in the panel discussion “The Road to Personalized Medicine.” 23andMe is a personal genomics pioneer and now one of the “unicorns,” which are startups valued at $1 billion or more. See Dr. Emily Drabant Conley’s bio here.